Over the past twenty years, the field of targeted protein degradation (TPD) has made significant strides as a novel therapeutic approach, utilizing either monovalent agents (molecular glues) or heterobifunctional molecules (PROTACs®). This collection of Best Practices outlines the fundamental principles and methodologies for developing PROTACs®. It includes three sections and a practical case study. 💻 Watch the webinars: https://buff.ly/4fPygsD 🔗 Download the set: https://buff.ly/4131kby
Professor an der Eberhard Karls Universität Tübingen
3dVery nice work Kurt Ritter and EFMC - European Federation for Medicinal Chemistry and Chemical Biology Best Practices team. Thanks for making all the effort to provide the #MedChem and #ChemicalBiology communities with such valuable ressources. Looking forward to discussing our progress on Best Practices for covalent modalities! 😃